Showing results (1251-1260 of 1,370) with videos related to
Sort By:
Pageof 137
Clinical and Translational Medicine|June 20, 2023
Trans-ethnic polygenic risk scores for body mass index: An international hundred K+ cohorts consortium studyHui-Qi Qu, John J Connolly, Peter Kraft, et al.Journal of Medicinal Chemistry|September 5, 2003
Synthesis and discovery of macrocyclic polyoxygenated bis-7-azaindolylmaleimides as a novel series of potent and highly selective glycogen synthase kinase-3beta inhibitorsGee-Hong Kuo, Catherine Prouty, Alan DeAngelis, et al.Medrxiv : the Preprint Server for Health Sciences|January 30, 2023
Trans-ethnic Polygenic Risk Scores for Body Mass Index: An International Hundred K+ Cohorts Consortium StudyHuiqi Qu, John J Connolly, Peter Kraft, et al.The New England Journal of Medicine|September 2, 2015
Randomized Trial of Benznidazole for Chronic Chagas' CardiomyopathyCarlos A Morillo, Jose Antonio Marin-Neto, Alvaro Avezum, et al.Stroke|May 7, 2026
Predictors of Hematoma Expansion and Response to Andexanet in Patients With Intracerebral Hemorrhage: Secondary Analyses of the ANNEXA-I Randomized Clinical TrialAshkan Shoamanesh, Stuart J Connolly, Andrew M Demchuk, et al.Cell|July 5, 2016
Nfib Promotes Metastasis through a Widespread Increase in Chromatin AccessibilitySarah K Denny, Dian Yang, Chen-Hua Chuang, et al.Journal of the American College of Cardiology|September 21, 2019
Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus AspirinJohn W Eikelboom, Jacqueline J Bosch, Stuart J Connolly, et al.Stroke|August 13, 2019
Efficacy and Safety of Rivaroxaban Versus Aspirin in Embolic Stroke of Undetermined Source and Carotid AtherosclerosisGeorge Ntaios, Balakumar Swaminathan, Scott D Berkowitz, et al.Bioorganic & Medicinal Chemistry Letters|May 30, 2008
Discovery of novel 4-amino-6-arylaminopyrimidine-5-carbaldehyde oximes as dual inhibitors of EGFR and ErbB-2 protein tyrosine kinasesGuozhang Xu, Lily Lee Searle, Terry V Hughes, et al.Journal of the American College of Cardiology|July 2, 2021
Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery DiseaseJohn W Eikelboom, Deepak L Bhatt, Keith A A Fox, et al.Pageof 137